Ejaculatory and Orgasmic Dysfunction Registry

The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction.

Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ejaculatory Dysfunction Anejaculation Anorgasmia Delayed Ejaculation Dysejaculation Dysorgasmia Genital Diseases Genital Diseases, Male Male Urogenital Diseases Mental Disorders Premature Ejaculation Sexual Dysfunction, Physiological Sexual Dysfunctions, Psychological Urogenital Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The Male Fertility and Peyronie's Clinic

Orem, Utah, 84057, United States

Location status: Recruiting

Location contact

Holli Burgon

SUB_INVESTIGATOR

Landon Trost, MD

CONTACT

[email protected]

888-655-0015

About this study

The objective of the current study is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. To accomplish this registry, CURE PD has partnered with the Sexual Medicine Society of North America (SMSNA) to help inform sexual medicine providers of the existence of the study and to help encourage patients to enroll.

Subjects meeting criteria will be offered study entry by their local provider who will refer them to an email address to indicate their interest. Participants will then be administered questionnaires at baseline and every 3 months x 1 year, followed by every 6 months x 2 years. Patient partners will also be allowed to enroll and will receive questionnaires on the same schedule (baseline, q3 months x 1 year, q6 months x 2 years).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men being treated for either ejaculatory and/or orgasmic dysfunction
For partners, inclusion is being a sexual partner of a man with ejaculatory and/or orgasmic dysfunction who is receiving treatment

Exclusion criteria

None

Treatment and study plan

Primary outcomes

Primary Objective

Time frame: 3 years

Report subjective efficacy of therapies used to treat ejaculatory dysfunction. Study participants will have the option of indicating if they had used any treatments to treat ejaculatory disorders. If so, they will then be asked to measure its efficacy at improving their symptoms using a 1-10 scale (10 being very effective).

Sponsors and collaborators

Lead sponsor

Charitable Union for the Research and Education of Peyronie's Disease

Other

Registry information

Official study title

Ejaculatory and Orgasmic Dysfunction Registry (Climax Registry)

Important dates

Study start: 2024
Primary completion: 2029
Study completion: 2029
First posted: Sep 20, 2024
Registry last updated: Feb 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed